Isotonic saline 0,9%
Isotonic saline 0,9% is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Registry-listed formulations
This catalogue entry has no confirmed scientific concept.
Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.
2 source entries across 2 studies. This list may not include all unresolved or historical entries.
- Isotonic saline 0.9%Registry intervention
Molecular identity unconfirmed
View study and source - Isotonic saline 0,9%Registry intervention
Linked study entry; product equivalence not established
View study and source
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
2
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
1
trials recruiting
4
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Peripheral TMD Pain Mechanisms and the Effect by Botulinum Toxin A
Dexmedetomidine vs Ketofol on Delirium in Children Undergoing Congenital Inguinal Hernia Repair
PVP-I Nasal Sprays and SARS-CoV-2 Nasopharyngeal Titers (for COVID-19)
Effects of Intraoperative Magnesium Sulfate on Perioperative Pain Relief After Spine Surgery
Clinical Trials (4)
Peripheral TMD Pain Mechanisms and the Effect by Botulinum Toxin A
Dexmedetomidine vs Ketofol on Delirium in Children Undergoing Congenital Inguinal Hernia Repair
PVP-I Nasal Sprays and SARS-CoV-2 Nasopharyngeal Titers (for COVID-19)
Effects of Intraoperative Magnesium Sulfate on Perioperative Pain Relief After Spine Surgery
All 4 trials loaded
Drug Details
- Intervention Type
- Drug
- Total Trials
- 4